1. Home
  2. SOPH

as of 12-16-2025 10:29am EST

$4.73
+$0.01
+0.21%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Chart Type:
Time Range:
Founded: 2011 Country:
Switzerland
Switzerland
Employees: N/A City: N/A
Market Cap: 330.4M IPO Year: 2021
Target Price: $7.00 AVG Volume (30 days): 105.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.12 EPS Growth: N/A
52 Week Low/High: $2.58 - $5.30 Next Earning Date: 11-04-2025
Revenue: $73,297,000 Revenue Growth: 13.66%
Revenue Growth (this year): 18.32% Revenue Growth (next year): 15.61%

AI-Powered SOPH Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 18 hours ago

AI Recommendation

hold
Model Accuracy: 66.67%
66.67%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: